Cent Eur J Public Health 2008, 16(Supplement):S27-S28

The Beijing Cochrane Workshop on Cervical Cancer Prevention: Cytology Versus HPV-Based Cervical Cancer Screening

Marc Arbyn1, Jack Cuzick2
1 Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium; ECCG (European Cooperation on development and implementation of Cancer screening and prevention Guidelines), IARC, Lyon, France
2 Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, Wolfson Institute of Preventive Medicine and Cancer Research, UK, Queen Mary University of London, London, UK

Keywords: cervical cancer, cervical intraepithelial neoplasia, primary screening, HPV, cytology, randomized trials, systematic review, Cochrane review

Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Arbyn M, Cuzick J. The Beijing Cochrane Workshop on Cervical Cancer Prevention: Cytology Versus HPV-Based Cervical Cancer Screening. Cent Eur J Public Health. 2008;16(Supplement):S27-28. PubMed PMID: 35841222.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, FerenczyA, et al. Human papillomavirus DNAversus Papanicolaou screening tests for cervical cancer. N Engl J Med. 2007 Oct 18;357(16):157988. Go to original source... Go to PubMed...
    2. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007 Oct 18;357(16):1589-97. Go to original source... Go to PubMed...
    3. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006 Aug 21;24 Suppl 3:S78-89. Go to original source... Go to PubMed...
    4. CuzickJ,ClavelC,PetryKU,MeijerCJ,HoyerH,RatnamS,etal.Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006 Sep 1;119(5):1095-101. Go to original source... Go to PubMed...
    5. Schatzkin A, Connor RJ, Taylor PR, Bunnag B. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am J Epidemiol. 1987 Apr;125(4):672-8. Go to original source...
    6. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007 Nov 24;370(9601):1764-72. Go to original source... Go to PubMed...
    7. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst. 2003 Jan 1;95(1):46-52. Go to original source... Go to PubMed...
    8. Cuzick J, SzarewskiA, Mesher D, Cadman L,Austin J, Perryman K, et al. Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-results from the Hammersmith study. Int J Cancer. 2008 May 15;122(10):2294-300. Go to original source... Go to PubMed...
    9. Arbyn M, Dillner J, Schenck U, Nieminen P, Weiderpass E, Da Silva D, et al. Chapter 3: Methods for screening and diagnosis. In: Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al, editors. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities; 2008. p. 69-152.

    Return to the content